Bellevue Group’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,250
Closed -$426K 213
2019
Q2
$426K Buy
+6,250
New +$426K 0.01% 147